Cancer Care
Medanta Institute of Cancer Care is a one-stop destination for comprehensive treatment of all cancers – from risk assessment, prevention to multi-modal treatment and palliative care. We understand that each cancer patient is unique and so should be their treatment plan. For this, we have developed a.......
Medanta Institute of Cancer Care is a one-stop destination for comprehensive treatment of all cancers – from risk assessment, prevention to multi-modal treatment and palliative care. We understand that each cancer patient is unique and so should be their treatment plan. For this, we have developed a Tumor Board that includes organ-specific cancer surgeons, radiologists, and medical and haemato oncologists. Our cancer specialists, many of whom are pioneers in their fields, work together seamlessly with surgeons across departments and specialities to provide the most holistic and cutting-edge care using technologies such as Varian Edge, CyberKnife VSI Robotic Radiosurgery, VMAT, IGRT, Tomotherapy and other innovative diagnostic and imaging equipment. Our institute is also actively involved in research, creating more robust protocols, and ushering early adoption of newer therapies such as CAR T-cell Therapy.
At Medanta Cancer Institute, we have a dedicated team of oncologists, organ-specific cancer surgeons, and experts from various specialities, including radiation therapy, and medical and haemato oncology, to deliver care that addresses all aspects of the disease.
The Tumor Board take a unique multi-disciplinary approach to curate a customised treatment plan for each patient depending on the type and stage of cancer. We also bear in mind each patient’s individual circumstances, values, and preferences.
Our specialists are backed by a skilled support network that includes specially trained oncology nurses, radiologists, pathologists, and genetic counsellors.
Immunotherapy is a form of cancer treatment that enhances the body's natural defenses to combat cancer. It involves using substances created either by the body or in a laboratory to improve the immune system's ability to identify and eliminate cancerous cells.
Robotic partial nephrectomy is a surgical procedure that employs robotic technology to remove only the diseased portion of a kidney while preserving the healthy tissue. This approach is used to treat kidney tumours, minimising the risk of kidney function loss and postoperative complications.
It is a condition that happens when normal cells in the liver become abnormal in appearance and behaviour. Malignant or cancerous cells that develop in the liver's normal cells cause the condition called hepatocellular carcinoma.
Blood cancer, such as leukemia or lymphoma, affects the blood-forming tissues in the body, leading to an abnormal production of blood cells and potentially life-threatening consequences.
Breast cancer is a type of cancer that originates in the cells of the breast. Though it is more common in women, it can also affect men. Symptoms of breast cancer may include a lump in the breast, changes in breast size or shape, nipple discharge, or skin changes on the breast. It is crucial to detect breast cancer early through regular breast screenings and self-examinations to ensure successful treatment.
CD45RA Depletion is a specialised technique used in allogeneic hematopoietic stem cell transplantation and cell therapy. CD45RA is a marker found on naïve T cells, which have not yet encountered antig..
Whether you are a donor or need an allogeneic transplant, blood stem cells can be collected from your bloodstream or bone marrow. While the largest concentration of stem cells is in the bone marrow,..
TCR Alpha-Beta Depletion is an advanced technique used in haematopoietic stem cell transplantation (HSCT) to enhance the safety and efficacy of the procedure. T-cell receptors (TCRs) are proteins foun..
Chimeric Antigen Receptor (CAR) T cell therapy is a highly personalised, targeted and effective therapeutic approach for half-match transplantation and cancer. It involves genetically modifying a pati..
Donor Lymphocyte Infusion (DLI) is a valuable procedure in the post-transplant management of patients, supporting overall immune recovery, and fighting residual cancer cells and relapse. It involves i..
Mr. Dilip Rai
Rudrash Tiwari
Dr. Kanchan Kaur
Sujaya Walia
अदिति गोयल
Mukesh Jha
Mr. Ram Narayan Yadav
Mr. Dilip Rai
Rudrash Tiwari
Dr. Kanchan Kaur
Sujaya Walia
अदिति गोयल
Mukesh Jha
Mr. Ram Narayan Yadav
